News summary

Verdane partners with digital healthcare provider Yazen

Source: Verdane • Published: 08 Oct 2026, 05:59

Summarized by Masters of Longevity from Verdane.

Fresh capital will support the Swedish obesity-care provider’s expansion across Europe, where its markets already include Switzerland.

Verdane partners with digital healthcare provider Yazen
Key Takeaways
  • Verdane led the investment, with Evli Growth Partners also participating.
  • Yazen combines weight-loss medication with continuing support from multidisciplinary care teams.
  • The funding amount and round label were absent from the investor announcement.
Read the full article at Verdane ↗

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.